Afuco™ Anti-RSV ADCC Therapeutic Antibody (Felvizumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to respiratory syncytial virus. Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.
Supplier Creative Biolabs
Product # AFC-TAB-098
Pricing Inquiry
Host Human
Target RSV
Species Reactivity RSV
Type ADCC enhanced antibody
Applications IF, IP, Neut, FuncS, ELISA, FC
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback